Viral Suppression and Antiretroviral Medication Adherence Among Alcohol Using HIV-Positive Adults

International Journal of Behavioral Medicine

Volumn 21, Issue 5, 2014, Pages 811-820

  Kalichman, Seth C ^a   Grebler, Tamar ^a   Amaral, Christina M ^a   McNerney, Megan ^a   White, Denise ^a   Kalichman, Moira O ^a   Cherry, Chauncey ^a   Eaton, Lisa ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Alcohol use; HIV treatment; Medication adherence

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ALCOHOLISM; DRINKING BEHAVIOR; FEMALE; HIV INFECTIONS; HUMAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PREVALENCE; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; VIRUS LOAD;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PREVALENCE; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84919948006     PISSN: 10705503     EISSN: 15327558     Source Type: Journal    
DOI: 10.1007/s12529-013-9353-7     Document Type: Article

References (40)

1. Cohen MS, McCauley M, Gamble TR. HIV treatment as prevention and HPTN 052. Current opinion in HIV and AIDS. 2012;7(2):99–105. Epub 2012/01/10.
2. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. Epub 2011/07/20.
3. Parienti JJ, Das-Douglas M, Massari V, Guzman D, Deeks SG, Verdon R, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS ONE. 2008;3(7):e2783. Epub 2008/07/31.
4. Kobin AB, Sheth NU. Levels of adherence required for virologic suppression among newer antiretroviral medications. The Annals of pharmacotherapy. 2011;45(3):372–9. Epub 2011/03/10.
5. Yard SS, Huh D, King KM, Simoni JM. Patient-level moderators of the efficacy of peer support and pager reminder interventions to promote antiretroviral adherence. AIDS Behav. 2011;15(8):1596–604. Epub 2011/07/09.
6. Franke MF, Murray MB, Munoz M, Hernandez-Diaz S, Sebastian JL, Atwood S, et al. Food insufficiency is a risk factor for suboptimal antiretroviral therapy adherence among HIV-infected adults in urban Peru. AIDS Behav. 2011;15(7):1483–9. Epub 2010/08/18.
7. Waldrop-Valverde D, Ownby RL, Wilkie FL, Mack A, Kumar M, Metsch L. Neurocognitive aspects of medication adherence in HIV-positive injecting drug users. AIDS Behav. 2006;10(3):287–97. Epub 2006/02/18.
8. Nilsson Schonnesson L, Williams ML, Ross MW, Bratt G, Keel B. Factors associated with suboptimal antiretroviral therapy adherence to dose, schedule, and dietary instructions. AIDS Behav. 2007;11(2):175–83. Epub 2006/08/24.
9. Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52(2):180–202. Epub 2009/08/12.
10. Braithwaite RS, Kozal MJ, Chang CC, Roberts MS, Fultz SL, Goetz MB, et al. Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS. 2007;21(12):1579–89. Epub 2007/07/17.
11. Braithwaite RS, McGinnis KA, Conigliaro J, Maisto SA, Crystal S, Day N, et al. A temporal and dose–response association between alcohol consumption and medication adherence among veterans in care. Alcoholism, clinical and experimental research. 2005;29(7):1190–7. Epub 2005/07/28.
12. Kalichman SC, Amaral CM, White D, Swetsze C, Pope H, Kalichman MO, et al. Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS. AIDS Patient Care STDs. 2009;23(6):449–54. Epub 2009/05/06.
13. Sankar A, Wunderlich T, Neufeld S, Luborsky M. Sero-positive African Americans' beliefs about alcohol and their impact on anti-retroviral adherence. AIDS Behav. 2007;11(2):195–203. Epub 2006/06/27.
14. Piacenti FJ. An update and review of antiretroviral therapy. Pharmacotherapy. 2006;26(8):1111–33. Epub 2006/07/26.
15. Bertagnolio S, De Luca A, Vitoria M, Essajee S, Penazzato M, Hong SY, et al. Determinants of HIV drug resistance and public health implications in low- and middle-income countries. Antivir Ther. 2012;17(6):941–53. Epub 2012/08/18.
16. Bangsberg DR, Charlebois ED, Grant RM, Holodniy M, Deeks SG, Perry S, et al. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS. 2003;17(13):1925–32. Epub 2003/09/10.
17. Bangsberg DR, Moss AR, Deeks SG. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J Antimicrob Chemother. 2004;53(5):696–9. Epub 2004/03/27.
18. Gribble JN, Miller HG, Cooley PC, Catania JA, Pollack L, Turner CF. The impact of T-ACASI interviewing on reported drug use among men who have sex with men. Subst Use Misuse. 2000;35(6–8):869–90. Epub 2000/06/10.
19. Morrison-Beedy D, Carey MP, Tu X. Accuracy of audio computer-assisted self-interviewing (ACASI) and self-administered questionnaires for the assessment of sexual behavior. AIDS Behav. 2006;10(5):541–52. Epub 2006/05/25.
20. Saunders JB, Aasland OG, Babor TF, DeLaFuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addictions. 1993;88(6):791–804.
21. Maisto SA, Conigliaro J, McNeil M, Kraemer K, Kelley ME. An empirical investigation of the factor structure of the AUDIT. Psychol Assess. 2000;12(3):346–53. Epub 2000/10/06.
22. Bangsberg DR, Hecht FM, Charlebois ED, Chesney M, Moss A. Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS and Behavior. 2001;5:275–81.
23. Kalichman SC, Amaral CM, Cherry C, Flanagan JA, Pope H, Eaton L, et al. Monitoring antiretroviral adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clinical Trials. 2008;9:298–308.
24. Kalichman SC, Amaral CM, Stearns HL, White D, Flanagan JA, Pope H, et al. Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone. Journal of General Internal Medicine. 2007;22:1003–6.
25. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255–66. Epub 2000/08/06.
26. Ickovics JR, Meisler AW. Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J Clin Epidemiol. 1997;50(4):385–91. Epub 1997/04/01.
27. Simoni J, Kurth AE, Pearson C, Pantalone DW, Merrill J, Frick P. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behavior. 2006;10:227–331.
28. Bernhardt JM, Usdan S, Mays D, Martin R, Cremeens J, Arriola KJ. Alcohol assessment among college students using wireless mobile technology. J Stud Alcohol Drugs. 2009;70(5):771–5. Epub 2009/09/10.
29. McAuliffe TL, DiFranceisco W, Reed BR. Low numeracy predicts reduced accuracy of retrospective reports of frequency of sexual behavior. AIDS Behav. 2010;14(6):1320–9. Epub 2010/07/20.
30. Harel O, Pellowski J, Kalichman S. Are we missing the importance of missing values in HIV prevention randomized clinical trials? Review and recommendations. AIDS Behav. 2012;16:1382–93. Epub 2012/01/10
31. Bangsberg D, Kroetz DL, Deeks S. Adherence–resistance relationships to combination HIV antiretroviral therapy. Current HIV/AIDS Reports. 2007;4:65–72.
32. Bangsberg D, Deeks SG. Is average adherence to HIV antiretroviral therapy enough? J Gen Intern Med. 2002;17(10):812–3. Epub 2002/10/23.
33. Rasbach DA, Desruisseau AJ, Kipp AM, Stinnette S, Kheshti A, Shepherd BE, et al. Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: use of a rapid screening tool during routine clinic visits. AIDS Care. 2013;25(1):109–17. Epub 2012/06/08.
34. Mantri CK, Pandhare Dash J, Mantri JV, Dash CC. Cocaine enhances HIV-1 replication in CD4+ T cells by down-regulating MiR-125b. PLoS ONE. 2012;7(12):e51387. Epub 2012/12/20.
35. Weinhardt LS, Carey MP. Does alcohol lead to sexual risk behavior? Findings from event-level research. Annu Rev Sex Res. 2000;11:125–57. Epub 2001/05/16.
36. Bangsberg DR, Kroetz DL, Deeks SG. Adherence-resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep. 2007;4(2):65–72. Epub 2007/06/06.
37. Bangsberg DR, Deeks SG. Is average adherence to HIV antiretroviral therapy enough? J Gen Intern Med. 2002;17(10):812–3. Epub 2002/10/23.
38. Miller WR. Are alcoholism treatments effective? The Project MATCH data: response. BMC Public Health. 2005;5:76. Epub 2005/07/20.
39. Anton RF, O'Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA. 2006;295(17):2003–17. Epub 2006/05/04.
40. Simoni JM, Frick PA, Lockhart D, Liebovitz D. Mediators of social support and antiretroviral adherence among an indigent population in New York City. AIDS Patient Care STDs. 2002;16(9):431–9. Epub 2002/10/25.